Coya Therapeutics jobs and careers
Houston, TX, United States
About Coya Therapeutics
Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.
Founded in 2020 by Howard Berman and Howard Berman.
- Founded
- 2020
- Employees
- 1 to 10
- Total funding
- $51.8M
- Headquarters
- Houston
Leadership
The top of Coya Therapeutics's org chart, with how many people report into each leader.
Howard Berman
CEO & Chairman
11 reports
Fred Grossman D.O., FAPA
President and Chief Medical Officer
6 reports
David S. Snyder
CFO & COO
2 reports
Gregory MacMichael
Chief Technical Officer
Board
Stanley Appel
Advisor
Clive Svendsen
Advisor
Lawrence Steinman
Advisor
Anabella Villalobos
Director
Dov Goldstein
Director
Ann Lee
Director
Jobs at Coya Therapeutics
No open positions right now. Explore more companies on TheJobsMap.